846 Shares in Elevance Health, Inc. (NYSE:ELV) Acquired by Client 1ST Advisory Group LLC

Client 1ST Advisory Group LLC purchased a new stake in Elevance Health, Inc. (NYSE:ELV) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 846 shares of the company’s stock, valued at approximately $312,000.

Other institutional investors have also modified their holdings of the company. MQS Management LLC purchased a new stake in shares of Elevance Health during the 2nd quarter worth $217,000. AE Wealth Management LLC grew its holdings in shares of Elevance Health by 13.9% during the second quarter. AE Wealth Management LLC now owns 5,205 shares of the company’s stock worth $2,820,000 after buying an additional 637 shares during the last quarter. Sei Investments Co. grew its stake in shares of Elevance Health by 10.2% in the 2nd quarter. Sei Investments Co. now owns 123,872 shares of the company’s stock valued at $67,117,000 after purchasing an additional 11,513 shares during the last quarter. Ensign Peak Advisors Inc increased its stake in Elevance Health by 5.0% in the 2nd quarter. Ensign Peak Advisors Inc now owns 60,115 shares of the company’s stock valued at $32,574,000 after buying an additional 2,862 shares during the period. Finally, Frank Rimerman Advisors LLC increased its stake in shares of Elevance Health by 35,527.3% during the second quarter. Frank Rimerman Advisors LLC now owns 3,919 shares of the company’s stock worth $2,124,000 after acquiring an additional 3,908 shares during the period. Institutional investors and hedge funds own 89.24% of the company’s stock.

Elevance Health Price Performance

ELV opened at $384.26 on Monday. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26. The firm has a market cap of $89.12 billion, a price-to-earnings ratio of 14.01, a PEG ratio of 1.08 and a beta of 0.84. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The company has a fifty day simple moving average of $388.02 and a 200 day simple moving average of $466.63.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Thursday, October 17th. The company reported $8.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $9.66 by ($1.29). The company had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $8.99 EPS. Equities research analysts expect that Elevance Health, Inc. will post 32.96 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ELV. Morgan Stanley cut their price objective on Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research report on Wednesday, October 23rd. Raymond James set a $485.00 target price on Elevance Health in a research note on Friday, October 18th. UBS Group decreased their price target on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating on the stock in a research note on Friday, October 18th. Cantor Fitzgerald decreased their price objective on Elevance Health from $600.00 to $485.00 and set an “overweight” rating on the stock in a report on Friday, October 18th. Finally, Barclays lowered their target price on shares of Elevance Health from $622.00 to $501.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $536.53.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.